Posted by | April 9, 2012 10:19 | Filed under: Top Stories

A vaccine that targets a molecule in 90% of all cancers is now being tested on humans.

Results from the safety trial – on patients with blood cancer – found all had greater immunity to the disease after receiving the vaccine. Three of the seven patients who have completed the treatment are now free of the condition.

As a therapeutic vaccine it is designed to be given to patients to help their bodies fight cancer rather than the majority – known as prophylactic vaccines – that aim to prevent disease in the first place.

Researchers believe the jab could also tackle breast, prostate, pancreatic, bowel and ovarian cancers.

By: Alan

Alan Colmes is the publisher of Liberaland.